Minerva Neurosciences Reports Third Quarter 2016 Financial Results and Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Minerva Neurosciences (NERV) Misses Q3 EPS by 3c
November 3, 2016 8:42 AM EDTMinerva Neurosciences (NASDAQ: NERV) reported Q3 EPS of ($0.24), $0.03 worse than the analyst estimate of ($0.21).
Cash, cash equivalents and marketable securities as of September 30, 2016 were approximately $91.9 million, compared to $32.2 million as of December 31, 2015. As previously stated, Minerva expects that its cash, cash equivalents and... More
